These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2017608)

  • 1. Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections.
    Kohl S
    Rev Infect Dis; 1991; 13(1):108-14. PubMed ID: 2017608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo.
    Kohl S; Loo LS; Schmalstieg FS; Anderson DC
    J Immunol; 1986 Sep; 137(5):1688-94. PubMed ID: 3528287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus.
    Kohl S
    Rev Infect Dis; 1991; 13 Suppl 11():S950-2. PubMed ID: 1664132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.
    Kohl S; Strynadka NC; Hodges RS; Pereira L
    J Clin Invest; 1990 Jul; 86(1):273-8. PubMed ID: 2164044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human neutrophil--mediated destruction of antibody sensitized herpes simplex virus type I infected cells.
    Fujimiya Y; Rouse BT; Babiuk LA
    Can J Microbiol; 1978 Feb; 24(2):182-6. PubMed ID: 565669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells of salivary polymorphonuclear leukocytes and inhibition of peripheral blood polymorphonuclear leukocyte cytotoxicity by saliva.
    Ashkenazi M; Kohl S
    J Immunol; 1990 Jun; 144(12):4781-7. PubMed ID: 1972168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
    Melewicz FM; Shore SL; Ades EW; Phillips DJ
    J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cellular cytotoxicity of leukocytes for herpes simplex virus-infected cells in vitro and in vivo by intralipid.
    Loo LS; Tang JP; Kohl S
    J Infect Dis; 1982 Jul; 146(1):64-70. PubMed ID: 6806406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of route of delivery on neonatal natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells.
    Frazier JP; Kohl S; Pickering LK; Loo LS
    Pediatr Res; 1982 Jul; 16(7):558-60. PubMed ID: 6287398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection.
    Kohl S; West MS; Prober CG; Sullender WM; Loo LS; Arvin AM
    J Infect Dis; 1989 Nov; 160(5):770-6. PubMed ID: 2553825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells.
    Kohl S; Cahall DL; Walters DL; Schaffner VE
    J Immunol; 1979 Jul; 123(1):25-30. PubMed ID: 448149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of herpes simplex virus infection on murine antibody-dependent cellular cytotoxicity and natural killer cytotoxicity.
    Kohl S; Lawman MJ; Rouse BT; Cahall DL
    Infect Immun; 1981 Feb; 31(2):704-11. PubMed ID: 6260674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected autologous and allogeneic cells.
    Kohl S; Moore CM
    Immunology; 1983 Jan; 48(1):187-93. PubMed ID: 6848451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neonatal and maternal monocyte-macrophage and lymphocyte-mediated antibody-dependent cytotoxicity to cells infected with herpes simplex.
    Kohl S; Shaban SS; Starr SE; Wood PA; Nahmias AJ
    J Pediatr; 1978 Aug; 93(2):206-10. PubMed ID: 671153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent cellular cytotoxicity and natural killer cytotoxicity of peritoneal cells from nude mice to herpes simplex virus-infected cells.
    Kohl S; Tang JP; Loo LS
    Microbiol Immunol; 1984; 28(4):439-49. PubMed ID: 6748968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of naproxen therapy on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus.
    Gonik B; Loo LS; Bigelow R; Kohl S
    J Reprod Med; 1984 Oct; 29(10):722-6. PubMed ID: 6512781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation.
    Moraru M; Black LE; Muntasell A; Portero F; López-Botet M; Reyburn HT; Pandey JP; Vilches C
    J Immunol; 2015 Aug; 195(4):1676-84. PubMed ID: 26179905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
    Mester JC; Glorioso JC; Rouse BT
    J Infect Dis; 1991 Feb; 163(2):263-9. PubMed ID: 1846388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.